The Crooked Truth behind many PIII small biotechs is exactly where Bavi fell to "The Wolves" and and should be exposing these kinds of BP Tricks they pull all the time... What a shame some are capable of....
Let's keep in mind that lung cancer drugs from small biotech companies have a very poor track record in late-stage studies, but it's also hard to overlook highly statistically significant improvement like this.
5 Experimental Drugs That Could Make a Big Difference in Treating Lung Cancer
One of the five companies on the list is Clovis Oncology. For those that ssay PPHM is fairly priced by the market, I would like to hear your thesis as to what justifies a $2.25 BILLION market cap for CLOVIS when they don't yet have anything even in Phase II !!!!! And also for the Management haters - their CEO makes 708K and the CFO 489K. Fair?